EXTGX
Price
$51.13
Change
-$0.09 (-0.18%)
Updated
May 9 closing price
Net Assets
1.45B
RGAHX
Price
$71.62
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
Ad is loading...

EXTGX vs RGAHX

Header iconEXTGX vs RGAHX Comparison
Open Charts EXTGX vs RGAHXBanner chart's image
Eaton Vance Tx-Mgd Growth 1.2 A
Price$51.13
Change-$0.09 (-0.18%)
VolumeN/A
Net Assets1.45B
American Funds Growth Fund of Amer R5E
Price$71.62
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
EXTGX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EXTGX vs. RGAHX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXTGX is a Buy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 285B vs. EXTGX (1.45B). RGAHX pays higher dividends than EXTGX: RGAHX (0.54) vs EXTGX (0.19). EXTGX was incepted earlier than RGAHX: EXTGX (24 years) vs RGAHX (9 years). EXTGX (0.89) is less costly to investors than RGAHX (0.44). RGAHX is a more actively managed with annual turnover of: 25.00 vs. EXTGX (7.00). RGAHX has a lower initial minimum investment than EXTGX: RGAHX (250) vs EXTGX (1000). EXTGX annual gain was more profitable for investors over the last year : 8.28 vs. RGAHX (3.25). EXTGX return over 5 years is better than : 102.11 vs. RGAHX (44.87).
EXTGXRGAHXEXTGX / RGAHX
Total Expense Ratio0.890.44202%
Annual Report Gross Expense Ratio0.890.44202%
Fund Existence24 years9 years-
Gain YTD-2.739-2.478111%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.45B285B1%
Annual Yield % from dividends0.190.5436%
Returns for 1 year8.283.25254%
Returns for 3 years49.7033.40149%
Returns for 5 years102.1144.87228%
Returns for 10 years189.13N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics